Main Street Financial Solutions’s Royalty Pharma RPRX Stock Holding History

Main Street Financial Solutions’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.53M	Buy	98,699 +1,693	+2%	+$88.1K	0.35%	62
2026 Q1	$4.65M	Sell	97,006 -2,179	-2%	-$95.4K	0.34%	62
2025 Q4	$3.83M	Buy	99,185 +4,040	+4%	+$154K	0.29%	76
2025 Q3	$3.36M	Sell	95,145 -16,740	-15%	-$606K	0.22%	102
2025 Q2	$4.03M	Buy	111,885 +31,844	+40%	+$1.06M	0.29%	74
2025 Q1	$2.49M	Buy	+80,041	New	+$2.54M	0.22%	105
2024 Q4	–	Sell	-80,081	Closed	-$2.27M	–	555
2024 Q3	$2.27M	Buy	80,081 +34,611	+76%	+$959K	0.21%	98
2024 Q2	$1.2M	Buy	+45,470	New	+$1.26M	0.11%	167

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Main Street Financial Solutions's RPRX Position: Q2 2026 in Review

Main Street Financial Solutions increased its Royalty Pharma (RPRX) stake by 1.7% in Q2 2026, buying an estimated $88.1K and bringing the position to 98,699 shares worth $5.53M. The position accounts for 0.35% of the portfolio, ranked #62.

Main Street Financial Solutions first reported a position in RPRX in Q2 2024 and has held it in 8 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Main Street Financial Solutions held 98,699 shares of Royalty Pharma worth $5.53M as of Q2 2026.
Main Street Financial Solutions bought 1,693 Royalty Pharma shares in Q2 2026, an estimated $88.1K.
Royalty Pharma made up 0.35% of Main Street Financial Solutions's portfolio in Q2 2026, its #62 holding.
Main Street Financial Solutions first reported a position in Royalty Pharma in Q2 2024 and has held it in 8 quarters since.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Main Street Financial Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.